Sr Bioinformatician, Translational Medicine Fixed Term Contract – Oxford

Sr Bioinformatician, Translational Medicine Fixed Term Contract – Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transformative medicines which address unmet patient needs in oncology, infectious diseases and autoimmune disease. Our leaders in R&D are internationally recognised as some

Continue Reading

Senior Scientist II – Bioinformatician,Translational Medicine – Oxford

Senior Scientist II – Bioinformatician,Translational Medicine – Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transformative medicines which address unmet patient needs in oncology, infectious diseases and autoimmune disease. Our leaders in R&D are internationally recognised as some of

Continue Reading

Senior Laboratory Operations Technician – Oxford

Senior Laboratory Operations Technician – Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transformative medicines which address unmet patient needs in oncology, infectious diseases and autoimmune disease. Our leaders in R&D are internationally recognised as some of the biotech

Continue Reading

Principal Research Scientist – In Silico Biologics Design – Oxford

Principal Research Scientist – In Silico Biologics Design – Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transformative medicines which address unmet patient needs in oncology, infectious diseases and autoimmune disease. Our leaders in R&D are internationally recognised as

Continue Reading

Senior Bioinformatician – Protein Engineering – Oxford

Senior Bioinformatician – Protein Engineering – Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transformative medicines which address unmet patient needs in oncology, infectious diseases and autoimmune disease. Our leaders in R&D are internationally recognised as some of the

Continue Reading